OrbiMed Overview

  • Investor Type
  • Growth/​Expansion

  • Status
  • Active

  • Professionals
  • 69

Professionals

  • Investments
  • 1,030

  • Portfolio
  • 211

  • Exits
  • 544

Exits

OrbiMed General Information

Company Description

Founded in 1989, OrbiMed is a growth equity firm based in New York. The firm seeks to invest in companies operating in the biopharmaceutical, life sciences, digital health, healthcare services, medical devices, and diagnostic sectors based in Asia, Europe, and North America. This firm is a Registered Investment Adviser (RIA).

Business Details

Website
www.orbimed.com
Year Founded
1989
Investor Status
Actively Seeking New Investments
Primary Investor Type
Growth/Expansion
Other Investor Types
Lender/Debt Provider
Hedge Fund
Venture Capital
Corporate Office
  • 601 Lexington Avenue (at 53rd Street)
  • 54th Floor
  • New York, NY 10022-4629
  • United States
+1 (212)

OrbiMed Investments & Acquisitions (1,030)

OrbiMed’s most recent investment was a with Z-Alpha Therapeutics. The deal was made on 12-Nov-2026.

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Z-Alpha Therapeutics 12-Nov-2026 Drug Discovery Generating Revenue
Evommune 04-Nov-2026 Drug Discovery Generating Revenue
Dren Bio 29-Oct-2026 Drug Discovery Clinical Trials - Phase 2
Star Therapeutics 23-Oct-2026 Biotechnology Generating Revenue
Altis Labs 17-Sep-2026 Later Stage VC Decision/Risk Analysis Generating Revenue
You’re viewing 5 of 1,030 investments and acquisitions. Get the full list »

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

OrbiMed Exits (544)

OrbiMed has made a total of 544 exits. Its latest exit was from vVardis for on 13-Nov-2026. The exit was categorized as .

Company Name Exit Date Exit Type Exit Size
vVardis 13-Nov-2026
Binx 04-Nov-2026
Windward Bio Group 03-Nov-2026
Aspen Neuroscience 30-Oct-2026
Lycia Therapeutics 23-Oct-2026 IPO
You’re viewing 5 of 544 exits. Get the full list »

OrbiMed Fund Performance

Fund Name Vintage Size Dry Powder DPI RVPI TVPI IRR

This information is available in the PitchBook Platform. To explore OrbiMed‘s full profile, request access.

Request a free trial

OrbiMed Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

OrbiMed FAQs

  • What is OrbiMed?

    Founded in 1989, OrbiMed is a growth equity firm based in New York.

  • When was OrbiMed founded?

    OrbiMed was founded in 1989.

  • Where is OrbiMed headquartered?

    OrbiMed is headquartered in New York, NY.

  • What is OrbiMed's total asset value?

    OrbiMed has around in total assets under management.

  • How many investments has OrbiMed made?

    OrbiMed has made 1,030 investments.

  • What has OrbiMed invested in?

    OrbiMed has made numerous investments in companies like Z-Alpha Therapeutics, Evommune, and Dren Bio within the Drug Discovery industry.

  • What has OrbiMed invested in recently?

    OrbiMed's latest investment was on 12-Nov-2026 in Z-Alpha Therapeutics, a company within the Drug Discovery industry.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process